Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–8 of 8 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06451497
- Conditions
- Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +58 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- NEXT Oncology Austin, TX 78758, Texas, United States
- NEXT Oncology San Antonio, Texas, United States
NCT04794322
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +31 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Kaiser Permanente - San Francisco San Francisco, California, United States
- Anne Arundel Health System Annapolis, Maryland, United States
- Johns Hopkins University School of Medicine Baltimore, Maryland, United States
NCT03586661
- Conditions
- Adnexal Diseases, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, +32 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02316834
- Conditions
- Adnexal Diseases, Fallopian Tube Diseases, Fallopian Tube Neoplasms, +28 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- The Woman's Hospital of Texas Houston, Texas, United States
- MD Anderson Regional Care Center-Katy Houston, Texas, United States
- MD Anderson Regional Care Center-Bay Area Nassau Bay, Texas, United States
Active, Not Recruiting
Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients
NCT05114421
- Conditions
- High Grade Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Peritoneal High Grade Serous Adenocarcinoma, +3 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian
NCT02208375
- Conditions
- Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +35 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery
NCT03943173
- Conditions
- Adnexal Diseases, BRCA-Mutated Ovarian Carcinoma, BRCA1 Gene Mutation, +45 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
NCT03907852
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +38 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- University of Miami Sylvester Cancer Center Miami, Florida, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- National Cancer Institute Bethesda, Maryland, United States